Tag - MNTA

Financial Institutions Inc. (Nasdaq:FISI), AAR Corp. (Nasdaq:AIR) and Zygo Corp. (Nasdaq:ZIGO) are among the biggest percentage gainers in Wednesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Somanetics Corp. (Nasdaq:SMTS), Green Bankshares Inc. (Nasdaq:GRNB), Hawk Corp (Nasdaq:HWK), Momenta Pharmaceuticals Inc. (Nasdaq:MNTA), Cheesecake Factory Inc. (Nasdaq:CAKE) and Princeton National Bancorp Inc. (Nasdaq:PNBC).

Transact Technologies Inc (Nasdaq:TACT), Momenta Pharmaceuticals Inc (Nasdaq:MNTA) and Ebix Inc (Nasdaq:EBIX) are among the new 52-week highs in Wednesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: ArcSight Inc (Nasdaq:ARST), Republic Banc KY  (Nasdaq:RBCAA), CardioNet Inc (Nasdaq:BEAT), Cal-Maine Foods Inc (Nasdaq:CALM), TeleCommunication Systems Inc (Nasdaq:TSYS) and K-Tron International Inc (Nasdaq:KTII).

Here are the new 52-week highs among small caps:

Bluegreen Corp (Nasdaq:BXG), Momenta Pharmaceuticals Inc (Nasdaq:MNTA) and Hawaiian Holdings Inc (Nasdaq:HA) are among the new 52-week highs in Tuesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Westwood Holdings Group Inc (Nasdaq:WHG), First Financial Corp (Indiana) (Nasdaq:THFF), Idenix Pharmaceuticals Inc (Nasdaq:IDIX), Cyberonics Inc (Nasdaq:CYBX), LTC Properties Inc (Nasdaq:LTC) and Merit Medical Systems Inc (Nasdaq:MMSI).

Here are the new 52-week highs among small caps:

Small-cap stocks plunged shortly after Friday’s opening, showed resilience during the first hour of trading but have exhibited a downward trend in afternoon trading. The uncertainty surrounding Fannie Mae (NYSE:FNM) and Freddie Mac (NYSE:FRE) combined with record-high crude oil prices have spurred a sell-off today. At 2:17 p.m. ET, the Russell 2000 (NYSE:IWM) was down 2.07, or 0.31%, at 668.37.

Investors responded tepidly to Treasury Secretary Henry Paulson’s short statement that the U.S. government is committed to “supporting Fannie Mae and Freddie Mac in their current form as they carry out their important mission.”

Fannie Mae has fallen some 24% this afternoon, and similar losses were pinned on Freddie Mac on high volume. Selling fury was fueled overnight by an article in the New York Times suggesting the government was considering a takeover of the embattled mortgage lending giants as the housing slump and credit crisis wallop the firms.

The freefall in federally chartered corporations, or GSEs, spilled over to the rest of the financial sector, with large caps such as Wachovia Corp. (NYSE:WB) down 9%, Merrill Lynch down 5% and Lehman Bros. (NYSE:LEH) off 15% in afternoon trading.

“Retail and credit issues sparked selling Thursday and remain a concern today. Volatility is high right now,” Nick Kalivas, vice president of financial research with MF Global, told SmallCapInvestor.com in an email interview. “I think FNM and FRE are vulnerable to further losses, but the market is thinking that the government will aid the GSEs in some way and keep the financial system whole.”

Small caps were able to outperform large caps during Thursday’s bounce, but Kalivas said the move was powered more by a recovery in oil and natural gas that sparked money pouring back into small-cap energy firms. “I think it is more a beta trade or a sector trade than a sign of the market’s overall health. I’m not reading . . .

Diamond Management & Technology Consultants Inc (Nasdaq:DTPI), Sucampo Pharmaceuticals Inc (Nasdaq:SCMP) and Momenta Pharmaceuticals Inc (Nasdaq:MNTA) are among the biggest percentage gainers in Friday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Pacific Booker Minerals Inc (Nasdaq:PBM), DrdGold ADR (Nasdaq:DROOY), TiVo Inc (Nasdaq:TIVO), Park View Federal Savings Bank (Nasdaq:PVFC), Colony Bankcorp Inc (Nasdaq:CBAN) and Syniverse Hldg Inc (Nasdaq:SVR).

Here are the biggest percentage gainers among small caps:

Momenta Pharmaceuticals Inc. (Nasdaq:MNTA) is up nearly 12% in trading today after the biopharmaceutical company announced ahead of the opening that the U.S. Food and Drug Administration accepted the Abbreviated New Drug Application for a generic version of Copaxone. The application was submitted by Sandoz, Inc., Momenta’s development partner for the drug. Copaxone is used to lower the frequency of relapses in patients with relapsing-remitting multiple sclerosis.

Shares of Momenta are at $14.63, up $1.55 from Thursday’s close. Trading volume is at about 300,000 shares, above the stock’s average.

Here are the biggest percentage gainers and losers in pre-market trading among companies with a market cap between $50 million and $750 million:

Biggest percentage gainers:

• Hansen Medical, Inc. (Nasdaq:HNSN), up 63%.
• Immersion Corp. (Nasdaq:IMMR), up 10%.
• Momenta Pharmaceuticals Inc. (Nasdaq:MNTA), up 8%.

Biggest percentage losers:

• Radware Ltd. (Nasdaq:RDWR), down 11%, after reporting a wider-than-expected first-quarter loss and lower revenues.
• BioMimetic Therapeutics Inc. (Nasdaq:BMTI), down 9%.
• Novogen Ltd. (Nasdaq:NVGN), down 8%.

Nextwave Wireless Inc. (Nasdaq:WAVE), GSI Commerce, Inc. (Nasdaq:GSIC) and Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) are among the biggest percentage gainers in Thursday's trading among companies with market capitalizations under $750 million.

Skechers USA, Inc. (NYSE:SKX), Encore Wire Corp. (Nasdaq:WIRE) and Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) are also among the top small-cap percentage gainers.

Here are Thursday's biggest percentage gainers among small caps:

The Russell 2000 (NYSE: IWM) posted a steep decline following news of weak economic reports. The small-cap index fell 19.54 points, or 2.77%, to 686.18, its third consecutive decrease. The Dow Jones Industrial Average (INDU) lost 315.79 points, or 2.51%, to 12,266.39.

On a year-to-date basis, the Russell 2000 has let go 10.42%, while the Dow is down 7.53% and the S&P 500 is off 9.38%.

Small-cap stocks started the session down and extended their losses as the day wore on and investors digested bearish economic news.

The U.S. Commerce Department reported before the start of trading that spending increased 0.4% in January, while personal income added 0.3%. Economists were expecting smaller increases of 0.2%.

But the rise in consumption went to cover inflation. The same report showed that the price index for personal consumption expenditures rose 0.4%, while the core index, which excludes the costs of food and energy, climbed 0.3%.

In other economic news, the National Association of Purchasing Managers-Chicago reported after the opening that its index of regional business conditions fell to its lowest level since December 2001, while the University of Michigan’s final figures for February consumer confidence showed the worst result since 1992.

One of the biggest losers in today’s sell-off was general merchandise retailer Duckwall-ALCO Stores, Inc. (Nasdaq: DUCK), which slumped to a new 52-week low on news of a disappointing 2008 earnings forecast.

The Russell 2000 (NYSE: IWM) recovered from early losses and posted solid gains as a jump in the price of oil lifted energy stocks. The small-cap index added 11.34 points, or 1.43%, to 801.77. The Dow Jones Industrial Average (INDU) advanced 117.54 points, or 0.87%, to 13,660.94.

On a year-to-date basis, the Russell 2000 has increased 1.82%, while the Dow has added 9.51% and the S&P 500 has gained 7.32%.

The price of oil jumped $3.01 to $96.99 a barrel today on news the U.S. Energy Information Administration forecasted that world oil demand growth in the next two quarters will be higher than it previously estimated and a shutdown in production in the North Sea due to expectations of stormy weather.

That led to a rise in shares of energy companies, helping to lift sagging stocks.

Futures were pointing up this morning on news that Citigroup Inc. (NYSE: C) has hired an expert to manage its $43 billion subprime mortgage portfolio and a raised price target for Internet giant Google Inc. (Nasdaq: GOOG).

The indices opened with a rise, but the bulls lost their footing following news that Redbook Research, a publisher of statistics on the U.S. retail market, reported a 0.4% drop in U.S. chain store sales in the final week of October. With consumption comprising about 70% of gross domestic product, a slowdown could spell trouble for the economy.

Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), Albany Molecular Research, Inc. (Nasdaq: AMRI) and Jaclyn, Inc. (AMEX: JLN)  are among the biggest percentage losers in Tuesday's trading among companies with market capitalizations under $500 million.

Here are today's biggest percentage losers:

The Russell 2000 (NYSE: IWM) has rebounded from losses this morning and is now little changed from its starting level. At 1:48 p.m. ET, the small-cap index had added 1.13 points, or 0.14%, to 791.56. The Dow Jones Industrial Average (INDU) was up 51.46 points, or 0.38%, to 13,594.86.

Small-cap stocks can’t seem to gain any traction, despite a generally bullish opening on news that Citigroup Inc. (NYSE: C) has hired an expert to manage its $43 billion subprime mortgage portfolio and a raised price target for Internet giant Google Inc. (Nasdaq: GOOG).

The indices opened with a rise, but the bulls were held by news that Redbook Research, a publisher of statistics on the U.S. Retail Market, reported a 0.4% drop in U.S. chain store sales in the final week of October. With consumption comprising about 70% of gross domestic product, a slowdown could spell trouble for the economy.

The Russell 2000 fell into the red about 30 minutes after the start of trading, but has been rising cautiously since bottoming out at 11 a.m. ET.

Meanwhile, the price of oil has added $2.71 to $96.69 a barrel as the U.S. Energy Information Administration said that world oil demand growth in the fourth quarter of 2007 and the first quarter of 2008 will be higher than it previously forecast.

The Russell 2000 (NYSE: IWM) is slipping into negative territory despite a generally bullish mood following upbeat news from major corporate players.

At 10:38 a.m. ET, the small-cap index had lost 2.77 points, or 0.35%, to 787.66. The Dow Jones Industrial Average (INDU) was up 15.93 points, or 0.12%, to 13,559.33.

The mood in pre-market trading was bullish following news that Citigroup Inc. (NYSE: C) has hired an expert to manage its $43 billion subprime mortgage portfolio. The New York-based bank caused a sell-off on Monday after announcing that it expects additional losses of $8 billion to $11 billion after already suffering $6.5 billion in credit-related losses in the third quarter.

The tech sector contributed to the positive sentiment after a broker research firm raised its price target for heavyweight Google Inc. (Nasdaq: GOOG), while Research In Motion Ltd. (TSE: RIM) received a brokerage recommendation.

In economic news, U.S. chain store sales fell 0.4% in the final week of October, according to Redbook Research, a publisher of statistics on U.S. Retail Market. The decline is a worrisome sign of lower consumer demand.

Investors will also paying attention to a speech by U.S. Federal Reserve chairman Ben Bernanke, who will be in Texas at a summit on microfinance in the United States. The speech is likely to be academic in nature, but Bernanke’s words will be analyzed for clues about the current state of the U.S. economy and hints about future monetary policy action.

Biotechnology company Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) disclosed this morning that its collaboration partner, Sandoz Inc., received a letter from the U.S. Food and Drug Administration stating that Sandoz' abbreviated new drug application for Enoxaparin Sodium Injection is “not approvable.”

The FDA said the application was not approvable because it did not adequately address the potential for immunogenicity of the drug product. Momenta said the FDA recommended that it, along with Sandoz, meet with the Office of Generic Drugs to determine additional information required to adequately address the concern.

Momenta said it’s working with Sandoz to identify the additional information necessary to obtain approval from the FDA.

Shares of Momenta Pharmaceuticals (MNTA) plummeted 45.52%, or $6.09, to $7.29 ahead of the opening bell. Shares of Momenta Pharmaceuticals have been trading in the range of $9.05 to $21.98 for the past 52 weeks.

Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), Jones Soda Co. (Nasdaq: JSDA) and Xinhua Finance Media Ltd. (Nasdaq: XFML) are among the most actively traded companies in Tuesday pre-market trading among those with market capitalizations under $750 million:

Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) reported the FDA’s review of its blood clotting drug M-Enoxaparin is probably going to be lengthier than previously projected.

These are the biggest percentage losers in Thursday's trading among companies with market capitalizations under $500 million:

 

The Russell 2000 has narrowed its early gains but is still in positive territory, while the Dow is flat. At 11:20 a.m. ET the Russell 2000 was up 1.28 points, or 0.15%, to 839.74. The Dow Jones Industrial Average was down 2.85 points, or 0.02%, to 13,424.88.

Shares of CryoCor, Inc. (Nasdaq: CRYO) are soaring, up $2.34, or 92%, to $4.88, following news the Advisory Panel of the U.S. Food and Drug Administration has recommended one of its medical devices for approval. The CryoCor Cardiac Cryoablation System is a catheter that uses extreme cold to destroy damaged heart tissue in order to treat cardiac arrhythmias, the San Diego-based company reported before the start of trading. The product has already been approved in Europe. The FDA typically heeds the advice of its panels. A final decision is expected in August.

The Russell 2000 index has moved up whole the Dow is spinning its wheels following news of mixed economic data.

At 10:12 a.m. ET the Russell 2000 had added 3.37 points, or 0.40 percent, to 841.83. Dow Jones Industrial Average was up 11.62 points, or 0.09 percent, to 13,439.35.

Gross domestic product increased 0.7% during the first quarter of 2007, according to revised figures reported by the U.S. Commerce Department before the opening bell. That’s above the previously estimated growth rate of 0.6%.

However, economists were forecasting a bigger upward adjustment, expecting GDP to rise 0.8%. The U.S. economy expanded 2.5% in the final three months of 2006.

The picture on the jobs front was rosier.

Jobless claims for the week ended June 23 fell 13,000 to 313,000 on a seasonally-adjusted basis, the Labor Department reported before the opening. Observers were expecting a decline of 9,000.

The following were the most actively traded companies in Thursday's trading among those with market capitalizations under $500 million: